A
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K2.0 MBAV Therapeutics, Inc.Jun 25, 3:04 PM ET·0001185185-15-001694
- 8-K30.3 KBAV Therapeutics, Inc.Apr 7, 4:49 PM ET·0001185185-15-000851
- SC 13D/A51.3 KBAV Therapeutics, Inc.Jan 21, 3:59 PM ET·0001185185-15-000132
- 44.9 KBAV Therapeutics, Inc.Jan 21, 3:52 PM ET·0001185185-15-000130
- 8-K2.5 MBAV Therapeutics, Inc.Jan 16, 4:14 PM ET·0001185185-15-000097
- 10-Q3.7 MBAV Therapeutics, Inc.Nov 17, 5:28 PM ET·0001185185-14-003160
- 10-Q3.8 MBAV Therapeutics, Inc.Aug 19, 2:55 PM ET·0001185185-14-002260
- S-17.5 MBAV Therapeutics, Inc.Jul 16, 5:27 PM ET·0001185185-14-001825
- SC 13D56.9 KBAV Therapeutics, Inc.Jul 16, 2:48 PM ET·0001185185-14-001813
- 44.9 KBAV Therapeutics, Inc.Jul 16, 2:46 PM ET·0001185185-14-001811
Insiders
3Tickers
No tickers on record
Addresses
business
20 EAST 68TH STREET, SUITE 204
NEW YORK, NY, 10065
mailing
20 EAST 68TH STREET, SUITE 204
NEW YORK, NY, 10065
Former Names
- Merica Corp.2013-12-27
- AQUINO MILLING INC2013-06-17